CD38-Targeted 89Zr-DFO-Daratumumab PET of Myeloma: Immuno-PET Impacting Clinical Care
- PMID: 39884767
- DOI: 10.2967/jnumed.124.269393
CD38-Targeted 89Zr-DFO-Daratumumab PET of Myeloma: Immuno-PET Impacting Clinical Care
LinkOut - more resources
Full Text Sources
Research Materials